Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess if a switch from MMF to myfortic® results in improved GI- and/or health-related quality of life outcomes, and to determine the proportion of liver transplant recipients who are experiencing any GI complaints under MMF-based immunosuppressive treatment.
Inclusion criteria
- patients who have received a liver transplant treated with mycophenolic acid